SutureTech
SutureTech is a surgeon-founded medical device company based in Durham, North Carolina, specializing in the development of innovative internal fixation implants and surgical instruments for soft tissue and tendon repair. The company is dedicated to advancing orthopedic procedures by delivering clinically informed, surgeon-driven solutions that streamline surgical steps, enhance repair strength, and improve patient outcomes. SutureTech's flagship product, RapidFix™, is an all-suture dual anchor system designed for efficient, reliable fixation of soft tissue to bone, and has received FDA 510(k) clearance.
What We Do
RapidFix™ is the worlds first tendon and ligament repair staple made entirely of suture material and is designed to be the most efficient and reliable way to repair soft tissue injuries. It features a 100% suture-based internal fixation device that streamlines surgical steps, reduces operative time, and enhances repair strength aiming to get the injured back healthy as quickly as possible.
Application Area
FDA Regulated Medical Devices
Key People
CEO/Founder
Lead Engineer
Senior Advisor – Finance & Corporate Development
News & Updates
Received FDA 510(k) clearance for the RapidFix™ all-suture dual anchor system, enabling commercialization in the U.S. market.
Selected as one of 64 startups in the MedTech Innovator 2025 Accelerator Cohort, recognizing SutureTech as a high-potential medical technology company.
SutureTech announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for RapidFix™, its flagship all-suture dual anchor system for soft tissue repair.
SutureTech was named one of 64 medtech startups in the 2025 MedTech Innovator Accelerator Cohort, selected from nearly 1,500 global applicants.
SutureTech announced as 2025 MedTech Innovator finalist for the grand prize.
SutureTech is 1 of 5 companies announced as MedTech innovator finalists. This represents just 5 out of approximately 1500 companies that applied to the 2025 MedTech Innovator program. This honor confirms SutureTech as a startup with significant potential to disrupt the market.